18
Oct
2010
14
Oct
2010
08
Oct
2010
16
Sep
2010
20
Aug
2010
13
Jul
2010
Posted in I - Series C, Q - 2Q10, R - SOUTH EAST, X - Device (Delivery), X - Vaccines, XX - NC
Liquidia Technologies (Research Triangle Park, NC) a development-stage company focused on improving delivery of inhaled therapeutics and vaccines via nanoparticles with optimized characteristics for increased target specificity, closed a $5M Series C financing, bringing the total round to $25M. Participants include Canaan Partners, Pappas Ventures, New Enterprise Associates, Morningside, Firelake Capital and PPD
06
May
2010
Posted in I - Series C, Q - 2Q10, R - SOUTH EAST, X - Device (Ophthalmology), XX - NC
TearScience (Morrisville, NC) a clinical-stage medical device company focused on the treatment of chronic evaporative dry eye due to obstructive Meibomian Gland Dysfunction, closed a $44.5M Series C financing. Participants include Essex Woodlands Health Ventures, Investor Growth Capital, General Catalyst, De Novo Ventures, Spray Ventures and Quaker Bio Ventures.
12
Apr
2010
Posted in I - Series C, Q - 1Q10, R - SOUTH EAST, X - Device (Delivery), X - Vaccines, XX - NC
Liquidia (Morrisville, NC) a development-stage company focused on improving delivery of inhaled therapeutics and vaccines via nanoparticles with optimized characteristics for increased target specificity, closed a $13M Series C financing, bringing the total round to $20M. Participants include Canaan Partners, Pappas Ventures, New Enterprise Associates, Morningside and Firelake Capital.
30
Mar
2010
03
Mar
2010
22
Feb
2010
Posted in I - Series B, Q - 1Q10, R - SOUTH EAST, X - Biologics Mfg., XX - NC
PhaseBio Pharmaceuticals (Research Triangle Park, NC) a development-stage biopharma company focused on elastin-like fusion proteins for improved expression and purification of biological, closed a $25M Series B financing. Participants include New Enterprise Associates, Hatteras Venture Partners, Johnson & Johnson Development Corp. and Fletcher Spaght Ventures.
21
Jan
2010
Posted in I - Series A, Q - 4Q09, R - SOUTH EAST, X - Biomarker, X - Device (Imaging), XX - TN
ABT Molecular Imaging (Knoxville, TN) medical imaging company developing a production platform to generate unit doses of molecular imaging drugs for positron emission tomography (PET) scanning at the point of use, closed a $9M Series A financing. Participants include Intersouth Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.
21
Jan
2010
Posted in I - Series B, Q - 4Q09, R - SOUTH EAST, X - Device (Abdominal), X - Device (Laparoscopic), XX - NC
TransEnterix (Durham, NC) a development-stage medical device company focused on a laparoscopic surgical platform for minimally invasive abdominal surgeries, closed a $55M Series B financing. Participants include Aisling Capital, Intersouth Partners, Quaker BioVentures, SV Life Science Advisers, Synergy Life Science Partners and Parish Capital Advisors.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb